Xanthine oxidase inhibitors treatment or discontinuation effects on mortality: evidence of xanthine oxidase inhibitors withdrawal syndrome
Objectives: This study investigates the impact of xanthine oxidase inhibitors (XOI) on mortality in patients with cardiovascular diseases. XOI withdrawal has been reported to increased mortality risk due to rapid adenosine triphosphate (ATP) deficiency. This study aims to determine whether XOI treat...
Saved in:
Main Authors: | Masanari Kuwabara (Author), Michikazu Nakai (Author), Yoko Sumita (Author), Yoshitaka Iwanaga (Author), Ryusuke Ae (Author), Takahide Kodama (Author), Ichiro Hisatome (Author), Naoyuki Kamatani (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Side Effects and Interactions of the Xanthine Oxidase Inhibitor Febuxostat
by: Andreas Jordan, et al.
Published: (2018) -
Xanthine oxidase and aldehyde oxidase contribute to allopurinol metabolism in rats
by: Yoshitaka Tayama, et al.
Published: (2022) -
Structure-activity relationships of fraxamoside as an unusual xanthine oxidase inhibitor
by: Rosa Maria Vitale, et al.
Published: (2017) -
Oxidized Resveratrol Metabolites as Potent Antioxidants and Xanthine Oxidase Inhibitors
by: Orinamhe G. Agbadua, et al.
Published: (2022) -
The potential renoprotection of xanthine oxidase inhibitors: Febuxostat versus allopurinol
by: Dong-Ryeol Ryu
Published: (2017)